Archimed
 
 
 
  • About Us
  • Fund
  • Support
  • Return
  • Our Companies
  • left
    • About Us
    • Our Companies
    • Our DNA
  • Fund
    • Our Investment Strategy
    • Our Investors
    • Our Funds
    • Our Charity Fund
  • Support
    • Our Value Creation
    • Our Team and Network
  • Return
    • Return to Investors
    • Return to People
    • Return to Society
  • right
    • News
    • JOIN OUR TEAM
    • Investor Portal
    • Contact

NEWS

Our Latest News

Majority owner ARCHIMED and partners CAPZA and Siparex finance add-on acquisition by European safety testing company - and French market leader - CARSO

Majority owner ARCHIMED and partners CAPZA and Siparex finance add-on acquisition by European safety testing company - and French market leader - CARSO

ARCHIMED reaches agreement to sell Bomi Group to UPS

 December

 16, 

2021

ARCHIMED buys a majority stake in SUANFARMA a leading manufacturer and distributor of active pharmaceutical and nutraceutical ingredients

 November

 18, 

2021

ARCHIMED buys Cardioline, Europe’s leader in cardiology-focused telemedicine

 November

 17, 

2021

ARCHIMED buys Cube, an innovative provider of membrane protein services for the biopharma research market

 November

 3, 

2021

ARCHIMED refinances Ad-Tech less than a year after purchase, returning more than a third of investment to shareholders

 October

 20, 

2021

ARCHIMED’s NAMSA returns more than a third of investment

 October

 7, 

2021

< 1 2 3 4 5 … 12 >
368
  • ARCHIMED © 2022
  • Our Eco Design Approach
  • Legal Notice
  • SFDR Disclosures
  • Contact Us
  • LinkedIn
    Go top

    Back to top